Published ahead of print on January 8, 2009, doi:10.1164/rccm.200809-1394CP
© 2009 American Thoracic Society doi: 10.1164/rccm.200809-1394CP
Antimicrobial Stewardship in the Intensive Care UnitAdvances and Obstacles1 Department of Medicine, Washington University in St. Louis School of Medicine, St. Louis, Missouri Correspondence and requests for reprints should be addressed to Marin H. Kollef, M.D., 660 South Euclid, Campus Box 8052, St. Louis, MO 63110. E-mail: mkollef{at}im.wustl.edu ABSTRACT Antimicrobial stewardship involves a multifaceted approach that strives to combat the emergence of resistance, improve clinical outcomes, and control costs by improving antimicrobial use. Therefore, stewardship is of great importance and relevance in the intensive care unit. Clinical decision support systems, biomarker-derived treatment algorithms, and improved knowledge regarding the different components of antimicrobial therapy represent some of the advances that have been made in stewardship. Yet, significant obstacles have prevented the full achievement of stewardship's goals, and approaches to confronting these obstacles should be appreciated. Clinicians should realize that antimicrobials are important therapeutic agents and strive to use them wisely.
Key Words: antiinfective agents biological markers infection therapeutics This article has been cited by other articles:
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||